Product Overview
Eganelisib (IPI-549) is a potent inhibitor of PI3K-? with >100-fold selectivity over other lipid and protein kinases. The biochemical IC50 for PI3K-? is 16 nM. This product is a PEG modified pre-formulated liposome with Eganelisib (IPI-549) loaded. It is supplied ready to use in vitro or in vivo studies.
Storage Buffer
292 mM sucrose, 0.5% DPBS (1X)
Concentration
2.0 mg/mL (Concentration Eganelisib); Lipid Concentration 60 mM
Storage
2 °C to 8 °C (do not freeze), protect from light